About the Report
Frequent advances in healthcare technologies have contributed to innovative and effective knee reconstruction procedures and devices. Growing preference for minimally invasive surgery is also key to developments in the market. Improvements in terms of surgical tools and procedures has affected the market substantially.
The rapidly growing demographic of geriatrics around the world, coupled with rising incidence of knee pain from ailments such as osteoarthritis is expected to contribute to the number of knee reconstruction services. Improvements in robotic surgical procedures with higher levels of accuracy will support the adoption of knee reconstruction devices on a global scale.
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for knee reconstruction devices. The report tracks the global sales of knee reconstruction devices in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the healthcare industry in general, and knee reconstruction devices in particular.
How Does the Historical Data for Knee Construction Devices Market Compare to Future Outlook?
As per the FMI report, the global knee reconstruction devices market has witnessed a major boost with growing developments in terms of device design and functionality. Relatively common cases of arthritis and knee pain issues have generated gains for market players. In addition, major regulatory bodies around the globe have eased authorizations as to improve market access.
During the covid-19 pandemic, knee reconstruction procedures went through a short-term slump owing to restrictions imposed on elective medical processes. Also, issues in terms of supply chains for components have limited market growth. However, the growing number of pending cases are expected to contribute to recovery and growth through 2021 and beyond.
In the near future, the global knee reconstruction devices market is expected to make significant advances expanding at a healthy CAGR of close to 6%. The coming decade is likely to prove lucrative to market players with the introduction of numerous new product offerings.
How are Design Innovations Disrupting the Market?
In recent years technologies such as 3D printing, artificial intelligence, and surgical robotics are making waves in the field of medical technology. Through 2021 and beyond these technologies are expected to become increasingly relevant, especially in the field of orthopedics. According to a statement by a DePuy Synthes spokesperson, there has been a steady transition towards ambulatory surgical centers owing to faster recovery and lower costs. Consequently, manufacturers are increasingly focused on smaller, portable and cost-effective product offerings.
Developments in AI are increasingly aiding surgeons to develop highly personalized plans for surgical procedures with analysis of factors such as knee motion, without affecting efficiency in terms of patient outcomes. These developments are also significantly aiding developments in the field of surgical robotics.
Furthermore, market leaders are focused on incorporating 3D technologies to improve on cost-efficiency of production while maintaining uniformity in industrial processes with advances in visualization, mobile applications and sensors.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
What are the Major Challenges Hindering Knee Reconstruction Device Manufacturers?
On one hand, knee reconstruction devices are rapidly finding roles in the global healthcare sector supported by government investments towards healthcare infrastructure. However, manufacturers face varying challenges which have the potential to adversely impact long-term developments in the industry.
For instance, knee reconstruction devices are cost-prohibitive to purchase limiting adoption rates. Also, market players have to keep up with exceedingly strict regulations by bodies such as the FDA. Furthermore, post-surgical issues especially in terms of biocompatibility is expected to remain an area of concern for market players for the foreseeable future.
How are Knee Reconstruction Procedures Driving Sales in the United States?
In recent years the United States has witnessed a notable increase in the number of joint reconstruction procedures, with hip and knee procedures being major areas of application. According to the Center of Orthopedic & Neurosurgical Care & Research, approximately a million hip and knee replacement surgeries are performed in the country every year, making them some of the more common orthopedic procedures performed.
Nearly 50% of all American adults are expected to develop osteoarthritis in one knee in their lifespan. Also, the report indicates that knee replacement surgeries are expected to grow by around 670% by 2030, reaching 3.5 million procedures annually.
Further, knee reconstruction devices are also finding roles in musculoskeletal pain treatment. Also, the presence of major manufacturers in the country will contribute significantly to developments in the industry in the long-term.
What Opportunities Can Market Players Leverage in the United Kingdom Market?
According to a report from the National Joint Registry, approximately 160,000 hip and knee replacements are performed in England and Wales each year. These procedures are carried out in around 400 hospitals across the country, with a third being managed by the independent sector, and the rest being administered by the National Health Services. Also, the rate of ACL reconstruction procedures has risen by around 12 times from 2 in every 100,000 people to more than 24 per 100,000 in the past two decades.
The UK market is set to open up rapidly, even as cases of chronic knee pain in the UK has increased with age affecting more than 60% in the population age of 75 and above. Knee reconstruction devices are also being deployed to treat soft tissue and sports-based injuries including ligament and muscle injuries in the region.
Why are Knee Reconstruction Devices Flourishing in China?
According to data from the Chinese Medical Journal, covering data from manufacturers and companies accounting for up to 95% of products approved by the National Medical Products Administration for artificial joints in the market. The number of cases for total knee arthroplasty (TKA), and unicondyle knee arthroplasty (UKA) have increased by almost 600% and more than 100% respectively between 2011 and 2019.
China is expected to post major gains, with a rise in disposable incomes and higher standards of living, encouraging the adoption of therapeutic options. Chinese pharmaceutical companies are investing in joint reconstruction offerings, which will widen sales prospects across East Asia, setting up positive growth estimates in the long-term.
Why are Manufacturers Targeting the German Market?
On average, orthopedic surgeons in Germany, perform 35 ACL reconstruction procedures, with frequent implementation of stability examinations and frequent femoral drilling techniques being witnessed in the country. Lack of descriptive statistics despite the growing number of ACL reconstructions remains a challenge in the industry.
As a result, healthcare providers in the country are incorporating standardized knee reconstruction devices to eliminate the issue. According to a report by the US National Library of Medicine, more than 200 cases of knee replacement surgeries per 100,000 people in the country account for the demand in the country. Consequently, growth prospects of the market in Germany remain positive through the end of the assessment period in 2031.
Why are Cement Implants Gaining Ground?
Knee reconstruction devices are classified into cemented implants, cementless implants, partial implants, and revision implants. Of these the share from cemented implants is projected to account for a larger market share through the end of the assessment period.
Cemented implants are expected to grow at more than 6% CAGR through the end of 2031. This can be attributed to benefits of easier control in terms of occlusion, superior passive fits, elimination of screw access holes, and long-term patient reconstruction outcomes as compared to cementless variants.
Will Hospitals Continue to Dominate Adoption Rates?
Hospitals, orthopedic clinics and ambulatory surgical centers are the primary end users of knee reconstruction devices. Hospitals will account for a relatively larger market share through the forecast period, which can be attributed to better access to capital and healthcare infrastructure.
On the other hand, orthopedic clinics are anticipated to display a relatively faster rate of growth at over 7% CAGR. This can be attributed to the demand for specialist equipment required in these facilities. Lower costs will also support the adoption of knee reconstruction devices in ambulatory surgical centers.
How are Trauma Applications Contributing to Market Growth?
Knee reconstruction devices are used for patients suffering from rheumatoid arthritis, osteoarthritis, and trauma. Osteoarthritis patients account for a relatively larger share of the market of close to 50%, which can be attributed to higher incidence of joint damage and knee pain.
However, advances in reconstruction devices and therapy practices will result in a faster rate of adoption by trauma patients accounting for more than 6% CAGR throughout the assessment period, driven by superior patient outcomes.
Knee Reconstruction Devices – Competitive Landscape
The global knee reconstruction devices market is moderately consolidated with leading market players estimated to hold major market share. Market leaders are increasingly focused on the development of new products, with investments into research & development efforts in line with regulatory standards aiming for faster approvals, and consolidating market position.
In January 2021, the Johnson & Johnson Medical Devices Company announced the FDA clearance for the VELYS Robotic-assisted solution designed for use with the company’s Attune Total Knee System, as a part of the effort in developing a connected technologies digital surgery platform.
In March 2021, Acutive Technologies announced the receipt of FDA clearance for its Citrespline and Citrelock ligament reconstruction devices, which are designed to prevent damage to soft tissue during the insertion process, with varying joints including knee reconstruction processes.
Also, Conformis Inc. announced the receipt of approval from the Therapeutic Goods Administration in Australia for its patient-specific iTotal PS total knee replacement system, which aims to provide patients with reconstruction processes tailored to individual human bodies.
Future Market Insights has also analyzed the following market players in the knee reconstruction devices market in its comprehensive report:
- Arthrex Inc.
- DePuy Synthes
- DJO Global
- Exatech Inc.
- Japan MDM Inc.
- Smith & Nephew Plc.
- Tornier Inc.
- United Orthopedics Corporation
- Zimmer Inc.
*This list is indicative - full details about the knee reconstruction devices market players are available upon request.
Knee Reconstruction Devices Market- Report Scope
Historical Data Available for
USD Million for Value
Key Regions Covered
North America, Latin America, Europe, Japan, Asia Pacific Excluding Japan, and Middle East & Africa
Key Countries Covered
United States, Canada, Brazil, Mexico, Argentina, Germany, United Kingdom, France, Italy, Spain, Nordic, China, Japan, South Korea, India, Thailand Singapore, Australia, GCC Countries, Turkey, Israel, and South Africa
Key Segments Covered
Product, End User, Indication, and Region
Key Companies Profiled
Market Overview, Key Market Trends, COVID-19’s Impact, Demand Analysis, Market Background, Segmental Analysis, Regional Profiling, Market Structure Analysis and Competition Analysis
Customization & Pricing
Key questions answered in the report
How will the knee reconstruction devices market expand through 2031?
According to Future Market Insights (FMI), the global knee reconstruction devices market is expected to gain impetus from expanding geriatric populations and incidence of bone and joint ailments, expanding at a healthy CAGR of close to 6% through 2031.
Which is the dominant knee reconstruction devices market?
North America is currently the leading regional market for knee reconstruction devices, driven by the U.S. healthcare sector accounting for major market share through the end of the assessment period. Growth in this region is largely attributed to a mature healthcare industry and favorable reimbursement policies.
How is COVID-19 impacting the knee reconstruction devices growth projections?
The COVID-19 pandemic has had a notable impact on the prospects of knee reconstruction devices application in the short term. Reduced sales and production owing to lockdown restrictions imposed by governments have hindered the demand for knee reconstruction devices. Moreover, the disruptions in component supply chains during the crisis will remain a matter of concern. However, demand is expected to recover steadily through 2021.
Which are the prominent knee reconstruction devices market players?
Prominent knee reconstruction devices market players include Zimmer, Inc., Stryker Corporation, DePuy Synthes, Smith & Nephew, Corin, United Orthopedic Corporation, Arthrex Inc., Exactech Inc., DJO Global, Japan Medical Dynamic Marketing and Tornier Inc.
Enquiry before Buying
- Is the knee reconstruction devices market research conducted by FMI?
Yes, the global knee reconstruction devices research report has been compiled by expert analysts of FMI through a combination of primary research and secondary research. To know more about how the research was conducted, you can speak to research analyst.
- What research methodology is followed by FMI?
FMI follows a methodology that encompasses demand side assessment of the market, and triangulates the same through supply side analysis. This methodology is based on use of standard market structure, methods and definitions. Request detailed methodology.
- Who are the respondents for primary research?
FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. For a full list of primary respondents, please reach out to us.
- What are the sources of secondary research?
FMI conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
- Is a sample of this report available for evaluation?
Yes, you can request a sample and it will be sent to you through an email.
- How can I buy this report?
FMI provides a secure online payment system to buy report seamlessly. You can buy the report securely and safely.
- Cemented Implants
- Cementless Implants
- Partial Implants
- Revision Implants
- Orthopedic Clinics
- Rheumatoid Arthritis
- North America (U.S. & Canada)
- Latin America (Mexico, Brazil, Argentina, Chile, Peru, & Rest of LATAM)
- Europe (Germany, U.K., France, Italy, Spain, BENELUX, Nordic, Russia, Poland, CIS Countries & Rest of Europe)
- Middle East and Africa (GCC Countries, Turkey, South Africa, Israel, & Rest of MEA)
- Asia Pacific excluding Japan (China, India, ASEAN, South Korea, Australia, & Rest of APEJ)